Developing tools to study immune responses in infectious diseases
Tetramer Research and Development - immunologic and infectious diseases
This study is all about making special tools that help scientists learn how our immune system fights infections and tumors, which could lead to better treatments for patients dealing with these health issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10678130 on NIH RePORTER |
What this research studies
This research focuses on creating and distributing specialized reagents that help scientists study how the immune system responds to infections and tumors. By producing class I, class II, and CD1 tetramers, the project aims to enhance our understanding of T cell activation and their role in fighting diseases. Patients may benefit from the insights gained through this research, as it could lead to improved treatments for infectious diseases and immune-related conditions.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals with infectious diseases or those involved in immunological research.
Not a fit: Patients with non-infectious diseases or those not engaged in immunological studies may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnostic tools and therapies for infectious diseases and immune disorders.
How similar studies have performed: Previous research has shown success in using similar tetramer approaches to enhance our understanding of immune responses.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Altman, John — Emory University
- Study coordinator: Altman, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.